An W G, Schulte T W, Neckers L M. 2000. The heat shock protein 90 antagonist geldanamycin alters chaperone association with p210bcr-abl and v-src proteins before their degradation by the proteasome. Cell Growth & Differentiation, 11, 355-360
Bagatell R, Whitesell L. 2004. Altered Hsp90 function in cancer: a unique therapeutic opportunity. Molecular Cancer Therapeuticsr, 3, 1021-1030
Bao E D, Sultan K R, Nowak B, Hartung J. 2008. Expression and distribution of heat shock proteins in the heart of transported pigs. Cell Stress Chaperones, 13, 459-66
Basso A D, Solit D B, Munster P N, Rosen N. 2002. Ansamycin antibiotics inhibit Akt activation and cyclin D expression in breast cancer cells that overexpress HER2. Oncogene, 21, 1159-1166
Blagosklonny M V, Toretsky J, Neckers L. 1995. Geldanamycin selectively destabilizes and conformationally alters mutated p53. Oncogene, 11, 933-939
Calnek B W, Witter R L. 1986. Marek’s disease-a model for herpesvirus oncology. Critical Reviews in Microbiology, 12, 293-320
Cho K O, Ohashi K, Onuma M. 1999. Electron microscopic and immunohistochemical localization of Marek’s disease (MD) herpesvirus particles in MD skin lymphomas. Veterinary Pathology Online, 36, 314-320
Cid C, Alvarez-Cermeno J C, Camafeita E, Salinas M, Alcazar A. 2004. Antibodies reactive to heat shock protein 90 induce oligodendrocyte precursor cell death in culture implications for demyelination in multiple sclerosis. The FASE Journal, 18, 409-411
Conroy S E, Gibson S L, Brunstrom G, Isenberg D, Luqmani Y, Latchman D S. 1995. Autoantibodies to 90 kD heat-shock protein in sera of breast cancer patients. Lancet, 345, 126.
Conroy S E, Latchman D S. 1996. Do heat shock proteins have a role in breast cancer? British Journal of Cancer, 74, 717-721
Conroy S E, Sasieni P D, Fentiman I, Latchman D S. 1998. Autoantibodies to the 90kDa heat shock protein and poor survival in breast cancer patients. European Journal of Cancer, 34, 942-943
Conroy S E, Tucker L, Latchman D S, Isenberg D A. 1996. Incidence of anti Hsp 90 and 70 antibodies in children with SLE, juvenile dermatomyositis and juvenile chronic arthritis. Clinical and Experimental Rheumatology, 14, 99-104
Donnelly A, Blagg B S. 2008. Novobiocin and additional inhibitors of the Hsp90 C-terminal nucleotide-binding pocket. Current Medicinal Chemistry, 15, 2702-2717
Ferrarini M, Heltai S, Zocchi M R, Rugarli C. 1992. unusual expression and localization of heat-shock proteins inhuman tumor cells. International Journal of Cancer, 51, 613-619
Giordano C, Vizza D, Panza S, Barone I, Bonofiglio D, Lanzino M, Sisci D, Amicis F D, Fuqua S A W, Catalano S, Andò S. 2013. Leptin increases HER2 protein levels through a STAT3-mediated up-regulation of Hsp90 in breast cancer cells. Molecular Oncology, 7, 379-397
Gress T M, Müller-Pillasch F, Weber C, Lerch M M, Friess H, Büchler M, Beger H G, Adler G, 1994. Differential expression of heat shock proteins in pancreatic carcinoma. Cancer Research, 54, 547-552
Hartson S D, Matts R L. 1994. Association of Hsp90 with cellular src-family kinases in a cell-free system correlates with altered kinase structure and function. Biochemistry, 33, 8912-8921
Hertlein E, Wagner A J, Jones J, Lin T S, Maddocks K J, Towns W H, Goettl V M, Zhang X, Jarjoura D, Raymond C A, West D A, Croce C M, Byrd J C, Johnson A J. 2010. 17-DMAG targets the nuclear factor-kappaB family of proteins to induce apoptosis in chronic lymphocytic leukemia: Clinical implications of HSP90 inhibition. Blood, 116, 45-53
Hrycaj P, Wurm K, Mennet P, Muller W. 1995. Antibodies to heat shock proteins in patients with pulmonary sarcoidosis. Sarcoidosis, 12, 124-130
Kaiser P, Underwood G, Davison F. 2003. Differential cytokine responses following Marek’s disease virus infection of chickens differing in resistance to Marek’s disease. Journal of Virolog, 77, 762-768
Kamal A, Thao L, Sensintaffar J, Zhang L, Boehm M F, Fritz L C, Burrows F J. 2003. A high-affinity conformation of Hsp90 confers tumour selectivity on Hsp90 inhibitors. Nature, 425, 407-410
Lang S A, Klein D, Moser C, Gaumann A, Glockzin G, Dahlke M H, Dietmaier W, Bolder U, Schlitt H J, Geissler E K, Stoeltzing O. 2007. Inhibition of heat shock protein 90 impairs epidermal growth factor-mediated signaling in gastric cancer cells and reduces tumor growth and vascularization in vivo. Molecular Cancer Therapeutics, 6, 1123-1132
Lei L, Bao E D. 2008. Hsp90 expression in acute heat-stressed broilers and heat stress damage. Scientia Agricultura Sinica, 41, 3816-3821. (in Chinese)
Li Y B, Pei L Y, Bao E D, Wang Z L, Zhao R Q. 2008. Relationship between distribution, transcription level of HSPs mRNA and immunity tissue pathological lesion of transport stressed pigs. Scientia Agricultura Sinica, 41, 1832-1837 (in Chinese)
Li Y B, Sun P M, Wang Z L, Bao E D. 2005. Relationship between pathological lesion and distribution of HSP27 in transport stressed pigs. Journal of Nanjing Agricultural University, 28, 83-87 (in Chinese)
Millson S H, Truman A W, King V, Prodromou C, Pearl L H, Piper P W. 2005. A two-hybrid screen of the yeast proteome for Hsp90 interactors uncovers a novel Hsp90 chaperone requirement in the activity of a stress-activated mitogen-activated protein kinase, Slt2p. Mpk1p. Eukaryot Cell, 4, 849-860
Ministry of Health of the People’s Republic China. 2008. The third national survey of cause of death in China. China Cancer, 17, 344-345 (in Chinese)
Modi S, Stopeck A, Linden H, Solit D, Chandarlapaty S, Rosen N, D’Andrea G, Dickler M, Moynahan M E, Sugarman S, Ma W, Patil S, Norton L, Hannah A L, Hudis C. 2011. HSP90 inhibition is effective in breast cancer: a phase II trial of tanespimycin (17-AAG) plus trastuzumab in patients with HER2-positive metastatic breast cancer progressing on trastuzumab. Clinical Cancer Research, 17, 5132-5139
Morimura T, Ohashi K, Sugimoto C, Onuma M. 1998. Pathogenesis of Marek’s disease(MD) and possible mechanisms of immunity induced by MD vaccine. Journal of Veterinary Medicine Science, 60, 1-8
Ohashi K, Zhou W, O’Connell P H, Schat K A. 1994. Characterization of a Marek’s disease virus BamHI-L-specific cDNA clone obtained from a Marek’s disease lymphoblastoid cell line. Journal of Virology, 68, 1191- 1195.
Pick E, Kluger Y, Giltnane J M, Moeder C, Camp R L, Rimm D L, Kluger H M. 2007. High HSP90 expression is associated with decreased survival in breast cancer. Cancer Research, 67, 2932-2937
Romanucci M, Marinelli A, Sarli G, Della Salda L. 2006. Heat shock protein expression in canine malignant mammary tumours. BMC Cancer, 6, doi:10.1186/1471-2407-6- 171
Sato S, Fujita N, Tsuruo T 2000. Modulation of Akt kinase activity by binding to Hsp90. Proceedings of the National Academy of Sciences of the United States of America, 97, 10832-10837.
Schulte T W, Blagosklonny M V, Ingui C, Len L. 1995. Disruption of the Raf-1-Hsp90 molecular complex results in destabilization of Raf-1 and loss of Raf-1-Ras association Journal of Biological Chemistry, 270, 24585- 24588.
Whitesell L, Sutphin P D, Pulcini E J, Martinez J D, Cook P H. 1998. The physical association of multiple molecular chaperone proteins with mutant p53 is altered by geldanamycin, an hsp90-binding agent. Molecular and Cell Biology, 3, 1517-1525.
Yahara I. 1992. Structure and function of heat shock proteins. Metabolic Disease, 29, 669-680.
Yufu Y, Nishimura J, Nawata H. 1992. High constitutive expression of heat shock protein 90 alpha in human acute leukemia cells. Leukemia Research, 16, 597-605.
Zhao R, Davey M, Hsu Y C, Kaplanek P, Tong A, Parsons A B, Krogan N, Cagney G, Mai D, Greenblatt J, Boone C, Emili A, Houry W A. 2005. Navigating the chaperone network: an integrative map of physical and genetic interactions mediated by the Hsp90 chaperone. Cell, 120, 715-727
Zhong L, Peng X, Hidalgo G E, Doherty D E, Stromberg A J, Hirschowitz E A. 2003. Antibodies to HSP70 and HSP90 in serum in non-small cell lung cancer patients. Cancer Detection and Prevention, 27, 285-290
Zhou S P, Cui Z Z. 2003. InfIuence of Marek’s disease virus infections on antibody titers against newcastle disease virus and infectious bursal disease virus vaccines. Chinese Journal of Preventive Veterinary Medicine, 25, 473-475 (in Chinese)
Zhu L, Bao E, Zhao R, Hartung J. 2009. Expression of heat shock protein 60 in the tissues of transported piglets. Cell Stress Chaperones, 14, 61-69. |
